Beraprost is also being studied for use in avoiding reperfusion injury. It is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension.. Reference standards of Beraprost Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Beraprost Sodium
Catalogue No.:PA 02 26000
CAS :
Molecular Formula : C24H29NaO5
Molecular Weight : 420.47
Sodium 4-((1R,2R,3aS,8bS)-2-hydroxy-1-((Z)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate
Catalogue No.:PA 02 26510
Molecular Weight : 420.48
(±)-Beraprost Sodium
Catalogue No.:PA 02 0261000
Molecular Formula : C24H30NaO5
Molecular Weight : 421.49
Methyl 4-(3-(3-((tert-butyldimethylsilyl)oxy)-5-oxocyclopent-1-en-1-yl)-2-((triethylsilyl)oxy)phenyl)butanoate
Catalogue No.:PA 02 0261001
Molecular Formula : C28H46O5Si2
Molecular Weight : 518.84
Methyl 4-((1R,2R,3aS,8bS)-2-hydroxy-1-((3S,E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate
Catalogue No.:PA 02 0261002
Molecular Formula : C25H32O5
Molecular Weight : 412.53
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
